Expression of Musashi-1 Increases in Bone Healing
MetadataShow full item record
AuthorPadial Molina, Miguel; Crespo Lora, Vicente; Martín Morales, Natividad; Abril García, Darío; Galindo Moreno, Pablo Antonio; Hernández Cortés, Pedro Manuel; O'Valle Ravassa, Francisco Javier
Musashi-1Runx2PeriostinMesenchymal stem cellsBone healing
Padial-Molina, M.; Crespo-Lora, V.; Candido-Corral, C.; Martin-Morales, N.; Abril-Garcia, D.; Galindo-Moreno, P.; Hernandez- Cortes, P.; O’Valle, F. Expression of Musashi-1 Increases in Bone Healing. Int. J. Mol. Sci. 2021, 22, 3395. [https://doi.org/10.3390/ijms22073395]
SponsorshipJunta de Andalucia European Commission CTS-138 CTS-1028
Musashi-1 (MSI1) is an RNA-binding protein that regulates progenitor cells in adult and developing organisms to maintain self-renewal capacities. The role of musashi-1 in the bone healing environment and its relation with other osteogenic factors is unknown. In the current study, we analyze the expression of MSI1 in an experimental model of rat femoral bone fractures. We also analyze the relation between MSI1 expression and the expression of two osteogenic markers: periostin (POSTN) and runt-related transcription factor 2 (RUNX2). We use histological, immunohistochemical, and qPCR techniques to evaluate bone healing and the expression of MSI1, POSTN, and RUNX2 over time (4, 7, and 14 days). We compare our findings with non-fractured controls. We find that in bone calluses, the number of cells expressing MSI1 and RUNX2 increase over time and the intensity of POSTN expression decreases over time. Within bone calluses, we find the presence of MSI1 expression in mesenchymal stromal cells, osteoblasts, and osteocytes but not in hypertrophic chondrocytes. After 14 days, the expression of MSI1, POSTN, and RUNX2 was significantly correlated. Thus, we conclude that musashi-1 potentially serves in the osteogenic differentiation of mesenchymal stromal cells and bone healing. Therefore, further studies are needed to determine the possibility of musashi-1 ' s role as a clinical biomarker of bone healing and therapeutic agent for bone regeneration.